The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 31
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte KARL T. WEBBER
__________
Appeal No. 2003-1024
Application No. 09/556,352
__________
ON BRIEF
__________
Before ADAMS, MILLS, and GREEN, Administrative Patent Judges.
GREEN, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s final rejection of
claims 5 and 6, which are reproduced below.
5. An article of manufacture comprising a pharmaceutical tablet or capsule for oral
ingestion, comprising spironolactone in an amount within a range of 10 to 20 milligrams.
6. An article of manufacture comprising a pharmaceutical tablet or capsule for oral
ingestion, comprising spironolactone in an amount within a range of 10 to 20 milligrams, so
as to be therapeutically effective in suppressing aldosterone-mediated myocardial fibrosis
without substantially increasing sodium excretion and without substantially reducing
potassium retention by the body.
Page: 1 2 3 4 5 6 Next
Last modified: November 3, 2007